0001209191-20-002077.txt : 20200106 0001209191-20-002077.hdr.sgml : 20200106 20200106180626 ACCESSION NUMBER: 0001209191-20-002077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAMSON MARVIN CENTRAL INDEX KEY: 0000901056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 20511416 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-02 0 0001016169 ANTARES PHARMA, INC. ATRS 0000901056 SAMSON MARVIN C/O ANTARES PHARMA, INC. 100 PRINCETON SOUTH, SUITE 300 EWING NJ 08628 1 0 0 0 Common Stock 2020-01-02 4 M 0 50000 2.18 A 101751 D Common Stock 2020-01-02 4 S 0 50000 4.59 D 51751 D Common Stock 2020-01-02 4 M 0 49395 2.18 A 101146 D Common Stock 2020-01-02 4 S 0 49395 4.60 D 51751 D Common Stock 2020-01-02 4 M 0 549 2.66 A 52300 D Common Stock 2020-01-02 4 S 0 549 4.60 D 51751 D Stock Option (right to buy) 2.18 2020-01-02 4 M 0 99395 0.00 D 2016-05-28 2025-05-27 Common Stock 99395 0 D Stock Option (right to buy) 2.66 2020-01-02 4 M 0 549 0.00 D 2018-06-07 2027-06-06 Common Stock 549 0 D The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning. The options vested and became excercisable in four quarterly installments over the one-year period following the grant date of May 28, 2015. The options vested and became exercisable in four quarterly installments over the one-year period following the grant date of June 7, 2017. /s/Keith Muckenhirn as attorney-in-fact for Marvin Samson 2020-01-06